Trading a PODD straddle lets you take a pure volatility position on Insulet Corp without committing to a direction. Insulet Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PODD straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PODD profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Insulet Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PODD straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PODD straddle is the cleanest expression of that view. Our scanner prices every PODD straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PODD straddle into a catalyst or short a PODD straddle to harvest decay, the options straddle setups that matter are all in one place.
